Key facts
- This page summarizes Nathaniel S. Gardiner's Form 4 filing for ENANTA PHARMACEUTICALS INC (ENTA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Feb 2024, 18:31.
Nathaniel S. Gardiner - 26 Feb 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- ENTA
- Reported as of
- 26 Feb 2024
- Net transaction value
- +$46,631
- SEC form
- 4
- Accepted by SEC
- 27 Feb 2024, 18:31:52 UTC
- Prior SEC filing
- 14 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathaniel S. Gardiner
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nathaniel S. Gardiner filed Form 4 for ENANTA PHARMACEUTICALS INC (ENTA) on 27 Feb 2024.
Change
- Previous filing in this sequence was filed on 14 Feb 2024.
- Current net transaction value: +$46,631.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ENTA
transaction
Common Stock
Options Exercise
- Transaction value
- $46,631
- Shares
- +5,187
- Change %
- +7.4%
- Price
- $8.99
- Shares after
- 75,688
- Date
- 26 Feb 2024
- Ownership
- Direct
ENTA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 35,926
- Date
- 26 Feb 2024
- Ownership
- By grantor retained annuity trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ENTA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,187
- Change %
- -6.2%
- Price
- $0.000000
- Shares after
- 77,813
- Date
- 26 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,187
- Exercise price
- $8.99
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children.
Footnote F2
Such option became or will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 22, 2023).